These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1239 related articles for article (PubMed ID: 16351799)
1. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]. Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799 [TBL] [Abstract][Full Text] [Related]
2. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen]. Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720 [TBL] [Abstract][Full Text] [Related]
3. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [TBL] [Abstract][Full Text] [Related]
5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
6. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611 [TBL] [Abstract][Full Text] [Related]
7. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382 [TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma]. Yong W; Zheng W; Zhang Y Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962 [TBL] [Abstract][Full Text] [Related]
9. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259 [TBL] [Abstract][Full Text] [Related]
10. [CEOP regimen in the treatment for non-Hodgkin's lymphoma]. Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140 [TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity]. Nie DH; Hu WH; Gao YH; Wu Y; Zhang SP Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):312-4. PubMed ID: 15312373 [TBL] [Abstract][Full Text] [Related]
12. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen]. Huang HQ; Jiang WQ; Wang W; Zhou ZM; Xia ZJ; Lin XB; Li YH; Xu RH; Zhang L; Xu GC; Sun XF; Liu DG; He YJ; Guan ZZ Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995 [TBL] [Abstract][Full Text] [Related]
13. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma]. Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071 [TBL] [Abstract][Full Text] [Related]
14. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx]. Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649 [TBL] [Abstract][Full Text] [Related]
15. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma]. Xiao J; Wang SS; Huang Y; Chen LK; Guan ZZ; Huang HQ; Xia ZJ; Xu RH; Lin TY Ai Zheng; 2006 Sep; 25(9):1173-7. PubMed ID: 16965665 [TBL] [Abstract][Full Text] [Related]
17. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma]. Hou M; Li L; Qiu M; Yan X; Zhu J; Gou HF Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070 [TBL] [Abstract][Full Text] [Related]
18. [Clinical features and prognosis of nasal type NK/T cell lymphoma]. Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622 [TBL] [Abstract][Full Text] [Related]
19. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202 [TBL] [Abstract][Full Text] [Related]
20. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]